FRULLANTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 6.388
EU - Europa 6.269
AS - Asia 2.431
SA - Sud America 501
AF - Africa 66
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.669
Nazione #
US - Stati Uniti d'America 6.303
IT - Italia 1.522
GB - Regno Unito 1.177
CN - Cina 895
RU - Federazione Russa 868
IE - Irlanda 723
SG - Singapore 709
DE - Germania 540
BR - Brasile 455
FR - Francia 334
SE - Svezia 329
HK - Hong Kong 281
FI - Finlandia 241
UA - Ucraina 199
KR - Corea 146
VN - Vietnam 112
NL - Olanda 102
IN - India 81
ES - Italia 60
CA - Canada 50
TR - Turchia 37
PL - Polonia 29
JP - Giappone 28
AT - Austria 25
CI - Costa d'Avorio 25
CZ - Repubblica Ceca 25
BD - Bangladesh 24
IR - Iran 24
BE - Belgio 22
MX - Messico 20
ZA - Sudafrica 17
CH - Svizzera 16
IQ - Iraq 12
AR - Argentina 11
EC - Ecuador 11
PK - Pakistan 11
ID - Indonesia 8
AU - Australia 7
MA - Marocco 7
PE - Perù 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CL - Cile 6
EE - Estonia 6
JM - Giamaica 6
LT - Lituania 6
SA - Arabia Saudita 6
AL - Albania 5
PH - Filippine 5
PT - Portogallo 5
VE - Venezuela 5
EU - Europa 4
GE - Georgia 4
HU - Ungheria 4
IL - Israele 4
MK - Macedonia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AZ - Azerbaigian 3
CO - Colombia 3
CY - Cipro 3
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
TM - Turkmenistan 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BW - Botswana 2
BY - Bielorussia 2
GR - Grecia 2
KG - Kirghizistan 2
MY - Malesia 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 15.661
Città #
Dallas 1.286
Southend 1.019
Dublin 705
Fairfield 584
Ashburn 532
Chandler 406
Singapore 399
Santa Clara 352
Siena 289
Hong Kong 275
Woodbridge 272
Beijing 245
Munich 245
Moscow 221
Cambridge 220
Houston 217
Seattle 211
Milan 203
Wilmington 188
Ann Arbor 183
Hefei 177
Jacksonville 155
Seoul 146
Helsinki 140
New York 113
Los Angeles 107
Princeton 94
Florence 84
Rome 84
Dong Ket 55
Nanjing 54
Boardman 50
Turku 46
São Paulo 44
San Mateo 43
San Diego 42
Dearborn 41
Lancaster 38
Nuremberg 35
Shanghai 33
Buffalo 32
Lauterbourg 31
Columbus 29
Bengaluru 28
Washington 28
Chicago 27
Düsseldorf 27
Málaga 27
London 26
Abidjan 25
Redondo Beach 25
Tokyo 25
Menlo Park 24
Warsaw 24
Brescia 23
Council Bluffs 22
Phoenix 22
Bologna 21
Padova 21
Stockholm 21
The Dalles 21
Fremont 20
Brussels 19
Lappeenranta 19
Aachen 17
Guangzhou 17
Brooklyn 16
Denver 16
Izmir 16
Portsmouth 16
Berlin 15
Ho Chi Minh City 15
Shenyang 15
Hanoi 14
Maastricht 14
Chennai 13
Hyderabad 13
Johannesburg 13
Hebei 12
Jinan 12
Montreal 12
Norwalk 12
Rio de Janeiro 12
Toronto 12
Vienna 12
Ferrara 11
Mexico City 11
Nanchang 11
Orem 11
Paris 11
Redwood City 11
Boston 10
Brasília 10
Brno 10
Comun Nuovo 10
Frankfurt am Main 10
Naples 10
Pisa 10
San Francisco 10
Tianjin 10
Totale 10.670
Nome #
A first update on mapping the human genetic architecture of COVID-19 507
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 496
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 435
MEIS2 gene is responsible for intellectual disability, cardiac defects and a distinct facial phenotype 417
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome 340
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 313
Genetic mechanisms of critical illness in COVID-19 306
An explainable model of host genetic interactions linked to COVID-19 severity 299
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 292
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 292
Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome 265
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 265
Alport syndrome: impact of digenic inheritance in patients management 263
Potentially treatable disorder diagnosed post Mortem by exome analysis in a boy with respiratory distress 263
Low-level TP53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia 256
Exome sequencing coupled with mRNA analysis identifies NDUFAF6 as a Leigh gene 248
Analysis of the Phenotypes in the Rett Networked Database 245
Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+/- patients and in foxg1+/- mice 244
Mapping the human genetic architecture of COVID-19 237
Personalized therapy in a GRIN1 mutated girl with intellectual disability and epilepsy 229
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 225
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 222
Commentary: Potential links between hepadnavirus and bornavirus sequences in the host genome and cancer 220
Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma 220
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 213
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 208
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 205
A polygenic model with common variants may predict lung adenocarcinoma risk in humans 201
Multiple genetic loci modulate lung adenocarcinoma clinical staging 197
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases 196
AAV-mediated FOXG1 gene editing in human Rett primary cells 192
Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk 190
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 190
FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung 188
Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients 188
A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A 187
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 187
Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue 185
null 182
Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer 181
Germline polymorphisms and survival of lung adenocarcinoma patients: A genome-wide study in two European patient series 180
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 175
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 173
Germline mutations in lung cancer and personalized medicine 169
Mouse Pulmonary Adenoma Susceptibility 1 Locus Is an Expression QTL Modulating Kras-4A 166
WES profiling of COVID-19 164
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 163
Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5 161
A pilot study of next generation sequencing–liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel–Trenaunay syndrome 161
Detection of cryptic mosaicism in X-linked alport syndrome prompts to re-evaluate living-donor kidney transplantation 159
Authors' reply: Comment to "Vinyl chloride exposure and cirrhosis: A systematic review and meta-analysis" 157
Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation 151
Clinical and molecular characterization of COVID-19 hospitalized patients 148
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor 138
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 138
Vinyl chloride exposure and cirrhosis: A systematic review and meta-analysis 136
null 133
MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy 132
Riorganizzazione dell’attività di Genetica Medica relativa ai test genetici per malattie rare in ottica LEAN 131
Private somatic mutations identified with liquid biopsy lead tumor progression in solid cancers 129
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 127
SELP Asp603Asn and severe thrombosis in COVID-19 males 126
Altered expression of neuropeptides in FoxG1-null heterozygous mutant mice 122
Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review 121
Whole-genome sequencing reveals host factors underlying critical COVID-19 119
Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era 117
Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors 117
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 116
Correction: New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells 115
PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis 112
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: a systematic review and meta-analysis 110
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 110
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells 107
The phenomenon of multidrug resistance in glioblastomas 103
Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males 102
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity 94
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 93
Editorial: Liquid biopsy and new omics technologies in vascular malformations 88
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome 86
Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide 84
Editorial: Pharmacogenetic landscape in human solid cancers 76
Editorial: Lung adenocarcinoma: from genomics to immunotherapy 72
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions 66
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility 56
Editorial: Current trends and future perspectives about liquid biopsy 55
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine 54
Blood circulating miRNAs as pancreatic cancer biomarkers: An evidence from pooled analysis and bioinformatics study 51
The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis 50
Liquid Biopsies 41
Editorial: Recent advancements in RNA-based and targeted therapeutics 41
Noninvasive Genetic Testing: Adhesive Patch-Based Skin Biopsy and Buccal Swab 38
Totale 16.022
Categoria #
all - tutte 52.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.142 0 0 0 0 114 110 107 175 120 229 140 147
2021/20221.208 141 143 75 89 56 43 63 40 60 120 144 234
2022/20231.626 90 139 166 190 124 318 109 142 143 57 94 54
2023/20241.472 70 47 170 89 62 355 390 60 22 60 40 107
2024/20253.463 102 146 345 216 419 233 227 223 321 161 374 696
2025/20264.104 557 1.096 1.052 1.066 333 0 0 0 0 0 0 0
Totale 16.022